Drugs - HealthQuill

Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a company statement.

Pfizer’s haemophilia A gene therapy cuts bleeding rates during trials

HQ Team July 25, 2024: Pfizer’s haemophilia A gene therapy has reduced bleeding rates in patients during an end-stage trial, according to a.

by HealthQuill
July 25, 2024
0 Comments

An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies to halt the trial.

Drugs Health Pharma

Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results

An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.

by HealthQuill
July 24, 2024
1 Comment

HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups than in the placebo or dummy group.

Drugs Health Pharma

PrEPVacc HIV trials’ results ‘surprising’ as dummy group clocks less infections

HIV vaccine trials conducted in Eastern and Southern Africa threw up surprising results when more infections were reported in the two vaccine groups.

by HealthQuill
July 24, 2024
0 Comments

The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to the company.

Drugs Health Pharma

Merck’s experimental RSV injection lowers infections in infants

The US-based Merck and Co.’s investigational medicine to protect infants from respiratory syncytial virus (RSV) disease has resulted in lowering infections, according to.

by HealthQuill
July 24, 2024
0 Comments

The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering from heart problems or stroke.

Drugs Health Pharma

Novo Nordisk’s Wegovy gets UK regulator nod to treat heart risks

The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.

by HealthQuill
July 24, 2024
0 Comments

The World Health Organization’s laboratory network has detected six variants of poliovirus type 2 (cVDPV2) in sewage samples in war-torn Gaza and warned of a global spread if it is not contained.

Drugs Health Pharma

Poliovirus type 2 detected in sewage samples in war-torn Gaza: WHO

The World Health Organization’s laboratory network has detected six variants of poliovirus type 2 (cVDPV2) in sewage samples in war-torn Gaza and warned.

by HealthQuill
July 23, 2024
0 Comments

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9 million HIV people not able to receive treatment owing to a shortage of funds and an anti-rights push, a report stated.

Drugs Health Pharma

Fund crunch, anti-rights push, slowing global target to end AIDS, UN says

A person dies every minute due to AIDS-related causes, and the world is off-track to achieve its goals with a quarter of 39.9.

by HealthQuill
July 23, 2024
0 Comments

Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to a company statement.

Drugs Health Pharma

US-based Agilent Technologies to acquire Canada’s Biovectra for $925m

HQ Team July 23, 2024: Agilent Technologies Inc., will acquire Canada-based Biovectra, a contract development and manufacturing company, for $925 million, according to.